Professor Bucciarelli-Ducci received her undergraduate degree (2001) and postgraduate fellowship in cardiology (2005) from the University of Rome “La Sapienza”, Italy. She then undertook courses and fellowships at Northwestern University in Chicago, University of Zurich, Harvard Medical School, Oxford University and more recently an MSc in Health Economics from LSE. She worked at the Royal Brompton Hospital as a senior CMR clinical and research fellow in 2006-2010 and in 2012 she was awarded a PhD in CMR from the National Heart and Lung Institute, Imperial College. She was appointed a consultant cardiologist at the Bristol Heart Institute and University of Bristol where she was headhunted in 2010 to build the CMR programme. In 2021 she then returned to Royal Brompton and Harefield Hospitals to lead the CMR clinical academic programme at Harefield. She is associate professor at King College London, School of Biomedical Engineering & Imaging. Since 2019 she is also the CEO of the Society for Cardiovascular Magnetic Resonance, the leading international association in the field of CMR with HQ in the USA. Previously, she held leadership positions in the European Association of Cardiovascular Imaging and European Society of Cardiology with whom she continues to have strong collaborations. She is an invited expert by the European Medicines Agency (EMA) of the European Union (on contrast agents) and by the International Atomic Energy Agency (IAEA) of United Nations (on medical imaging without use of radiations). She is in the scientific advisory board of the National Heart Centre Singapore and Centro de Investigaciones Cardiovasculares (CNIC) in Spain. She is the deputy editor of the European Heart Journal (one of the most important cardiology journals worldwide) for the cardiovascular imaging section. She is recipient of numerous prestigious prizes/ awards, including the NHS national Clinical Excellence Award (bronze)(2021), winner Imperial College Alumni Emerging Leaders award (2022), winner Excellence in Education Outstanding Mid-Career Educator Award, European Society of Cardiology (2023), Finalist Wesleyan Prize, Medical Women Federation UK (2017), Winner William Harvey Prize, Italian Society of Cardiology (2011), Finalist Melvin Judkins Young Clinical Imaging Investigator Award, American Heart Association (2010), and others.

A/Prof Sandhir B Prasad is a senior staff cardiologist and clinical lead in echocardiography at the Royal Brisbane and Women's Hospital. He is a Monash medical graduate, completed his training in cardiology at Wellington Hospital (NZ), and then completed research and clinical fellowships at Westmead Hospital (Sydney), MonashHeart (Melbourne) and Princess Alexandra Hospital (Brisbane). His PhD focused on the pathophysiology and prognostic implications of left ventricular diastolic dysfunction following myocardial infarction.

André heads the National Centre for Sports Cardiology that comprises a young team of multi-disciplinary researchers based at the HEART Lab, supported by St Vincent’s Institute and the Victor Chang Cardiovascular Research Institute. He has pioneered novel imaging techniques including exercise cardiac magnetic resonance imaging and contrast echocardiography. He has more than 300 peer-review publications and text-book chapters, serves on multiple international guideline statements and is regularly invited to present at all major international cardiology conferences.

Mark Nolan is a senior Non-Invasive Cardiologist working at Peter Mac Cancer Centre in Melbourne and Bendigo Health, as well as a Post-Doctoral Researcher at the Baker Heart and Diabetes Institute. He is an He has completed an Echocardiography Fellowship in Adelaide, Cardiac MRI and CT Fellowship in Toronto, and also a Cardio-Oncology Fellowship in Toronto. His PhD thesis examined the optimal use of cardiac imaging to guide treatment in cancer patients. He has first-author publications in Journal of American College of Cardiology: Cardiovascular Imaging, Journal of American College of Cardiology: CardioOncology and American Journal of Cardiology. His professional interests also include Cardio-Diabetology and Health Economics, and he has published in both of these fields. His recreational interests include bush walking in the Mornington Peninsula and reading about classical history. One of the things he likes most about medicine is the ability to both teach and learn.

Professor John Greenwood is the Director of the Baker Heart and Diabetes Institute, Melbourne, Australia and Adjunct/Visiting Professor at Melbourne University, Monash University, and also the University of Leeds, UK. As a consultant cardiologist for 20 years, he has specialised in coronary intervention and cardiovascular magnetic resonance (CMR) imaging. Professor Greenwood underwent his clinical and academic training in Leeds, UK, and in addition underwent specialist training in coronary intervention in Toulouse, France and Cardiovascular Magnetic Resonance (CMR) imaging at the Royal Brompton Hospital, London. His main focus of research has been the diagnosis and treatment of stable and unstable coronary artery disease. In terms of diagnostics, this particularly involved the use of CMR in terms of pulse sequence development and validation through large scale clinical trials. In terms of therapeutics, he has collaborated on a number of major multi-centre clinical trials designed to improve outcomes in patients undergoing primary PCI for acute ST elevation myocardial infarction or stable complex coronary artery disease. In particular, early phase clinical trials of drugs and devices to reduce infarct size in the setting of acute myocardial infarction. He is the immediate Past-President of the British Cardiovascular Society (BCS; 2021-2024) and a member of Council of The Royal College of Physicians, London. He was elected to the Board of BSCMR (British Society of Cardiovascular MR) in 2008, and became BSCMR President (2018-2020). He is past-Chair of the SCMR clinical trials committee (2015-2017) and member of the SCMR scientific programme committee (2016-2019). He was the SCMR representative on the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. He was a winner of the SCMR Gold Medal in 2023 and Associate Editor of JCMR (2017-2023). He is a member of the ESC Cardio-policy group (2022-2024), ESC Advocacy Committee (2021-current) and a past member of the Assembly of International Governors of the ACC (2021-2024). He has supervised/co-supervised to completion ~30 MD/PhD students and has ~400 peer-reviewed publications, including many in NEJM, Lancet, JAMA, Circulation, JACC and EHJ.

Prof Nathan Better is a Clinical Cardiologist and Nuclear Medicine Physician at Cabrini and Royal Melbourne Hospitals and is Academic Director of Cardiology Research and Director of Physician Training at Cabrini Hospital. He is the past Chairman of the International Advisory Panel of the American Society of Nuclear Cardiology, an Expert Lecturer at the IAEA in Vienna and is on the editorial board of the Journal of Nuclear Cardiology. His major interests include diagnosis and prognosis of coronary artery disease, cardiac amyloid and cardiac CT.

A/Prof Rebecca Kozor is a physician-researcher with roles as a consultant cardiologist at Royal North Shore Hospital Sydney and as Associate Professor at the University of Sydney. She has specialist expertise in cardiac imaging, particularly cardiovascular magnetic resonance imaging.

John is an imaging cardiologist at the Royal Brisbane and at St Andrews War Memorial Hospitals. He established the cardiac CT and CMR programs at the Royal Brisbane Hospital in 2008 and has taught on CT angiography courses in Perth, Adelaide, Sydney, and Singapore. His research has been published in a variety of journals, including The BMJ, The Lancet, and Heart. He was a co-author of the CSANZ position statement on calcium scoring and the national training guidelines of cardiac MRI. He served as a CSANZ representative on the Conjoint Committee for CT Coronary Angiography and he is a past president of ANZ-CMR.